Prognostic value and gene regulatory network of CMSS1 in hepatocellular carcinoma
Cancer Biomarkers · 2024
DOI: 10.3233/cbm-230209 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biomarkers, 2024. Verfasst von Cheng Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan,…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Gene Regulatory Networks, Biomarkers, Tumor. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Cms1 ribosomal small subunit homolog (CMSS1) is an RNA-binding protein that may play an important role in tumorigenesis and development. OBJECTIVE: RNA-seq data from the GEPIA database and the UALCAN database were used to analyze the expression of CMSS1 in liver hepatocellular carcinoma (LIHC) and its relationship with the clinicopathological features of the patients. METHODS: LinkedOmics was used to identify genes associated with CMSS1 expression and to identify miRNAs and transcription factors significantly associated with CMSS1 by GSEA. RESULTS: The expression level of CMSS1 in hepatocellular carcinoma tissues was significantly higher than that in normal tissues. In addition, the expression level of CMSS1 in advanced tumors was significantly higher than that in early tumors. The expression level of CMSS1 was higher in TP53-mutated tumors than in non-TP53-mutated tumors. CMSS1 expression levels were strongly correlated with disease-free survival (DFS) and overall survival (OS) in patients with LIHC, and high CMSS1 expression predicted poorer OS ([Formula: see text] 0.01) and DFS ([Formula: see text] 0.01). Meanwhile, our results suggested that CMSS1 is associated with the composition of the immune microenvironment of LIHC. CONCLUSIONS: The present study suggests that CMSS1 is a potential molecular marker for the diagnosis and prognostic of LIHC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
- Department of Operation Room, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
- Department of Breast, Guangzhou Red Cross Hospital, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, Guangdong, China.
Zitieren
APA
Chen, C., Wang, C., Liu, W., Chen, J., Chen, L., Luo, X., & Wu, J. (2024). Prognostic value and gene regulatory network of CMSS1 in hepatocellular carcinoma. Cancer Biomarkers. https://doi.org/10.3233/cbm-230209
Vancouver
Chen C, Wang C, Liu W, Chen J, Chen L, Luo X, et al. Prognostic value and gene regulatory network of CMSS1 in hepatocellular carcinoma. Cancer Biomarkers. 2024. doi:10.3233/cbm-230209
BibTeX
@article{Chen2024,
author = {Chen, Cheng and Wang, Caiming and Liu, Wei and Chen, Jiacheng and Chen, Liang and Luo, Xiangxiang and Wu, Jincai},
title = {Prognostic value and gene regulatory network of CMSS1 in hepatocellular carcinoma},
journal = {Cancer Biomarkers},
year = {2024},
doi = {10.3233/cbm-230209}
}
EUVIMED